Analyst consensus rating
BioHarvest Sciences Analyst Rating: none
Direct answer
BioHarvest Sciences's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.50.
Forecast evidence checked October 17, 2026.
Get free BioHarvest Sciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.85
- Average price target
- $10.50
- High price target
- $15.00
- Low price target
- $5.00
- Low target gap
- +170.3%
- Target upside
- +467.6%
- High target gap
- +710.8%
- Target range width
- 540.5%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioHarvest Sciences?
BioHarvest Sciences has a verified none consensus. The same dataset has an average price target of $10.50.
How far are BioHarvest Sciences's low and high targets from the recorded price?
The low target implies +170.3%, while the high target implies +710.8%.
How many analysts are included in BioHarvest Sciences's consensus?
The verified consensus includes 4 analysts.
How is BioHarvest Sciences's target upside or downside calculated?
The average target of $10.50 is divided by the recorded price of $1.85, then one is subtracted to produce +467.6%. This does not guarantee a future return.
When was BioHarvest Sciences's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.